
UNC Lineberger
@UNC_Lineberger
Followers
7K
Following
3K
Media
1K
Statuses
6K
North Carolina's only public comprehensive cancer center, serving patients at the N.C. Basnight Cancer Hospital. Today's best care. Tomorrow's best hope.
Chapel Hill, NC
Joined May 2009
RT @UrologyTimes: Kate Gessner, MD, PhD, (@kategessner_uro) outlines the clinical scenarios in which she finds genomic testing most useful.….
urologytimes.com
Kathryn H. Gessner, MD, PhD, outlines the clinical scenarios in which she finds genomic testing most useful.
0
5
0
UNC Lineberger's Claudio Battaglini, PhD, describes how exercise prescriptions can improve cancer patients' lives and life expectancy in an interview with the @PeoplesPharmacy
peoplespharmacy.com
Exercise physiologist Claudio Battaglini, PhD, describes how exercise prescriptions can improve cancer patients' lives and life expectancy.
0
1
3
RT @RobertFerrisMD: Excited to participate in this great event at such an amazing CCC, and bring our cancer centers closer to benefit colla….
0
2
0
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS, are leading the trial.
unclineberger.org
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS,...
0
0
3
On #WorldBreastCancerResearchDay, we honor our UNC Lineberger colleagues who are leading innovative research to improve and personalize breast cancer care. From identifying molecular subtypes that have transformed our understanding of the disease to pioneering real-time,
0
1
3
RT @RNADiscovery: Congratulations to our director @ChadPecot and his team for publishing “Inverted chimeric RNAi molecules synergistically….
0
3
0
.@ChadPecot, MD, and colleagues have developed a “two-in-one” molecule that targets hard-to-treat cancers by silencing two key genes — KRAS and MYC — while also delivering drugs directly to affected tumors.
unclineberger.org
Chad Pecot, MD, and colleagues have developed a “two-in-one” molecule that targets hard-to-treat cancers by silencing two key genes — KRAS and MYC — while also delivering drugs directly to affected...
0
0
1
RT @RobertFerrisMD: Exciting clinical trial approach to maximize outcomes with as few patients needed, driven by rational biomarker selecti….
0
2
0
UNC Lineberger has been awarded up to $28 million by @ARPA_H to lead EVOLVE—a groundbreaking adaptive clinical trial designed to transform metastatic breast cancer care. “EVOLVE takes a different approach to clinical research by using real-time biomarker data to adapt treatment.
0
3
11
RT @RobertFerrisMD: Beautiful work driven by insightful basic science with great translational applicability! @UNC_Lineberger.
0
3
0
RT @ChadPecot: What’s better than drugging one “undruggable” target? How about drugging 2 at the same time!. Now out in JCI our group repor….
0
12
0
After months of chemotherapy, @UNC_Health_Care nurse Alexis Long is thankful her latest test showed no leukemia cells — but she knows her best chance at curing aplastic anemia and its complications is a bone marrow transplant.
cbs17.com
Alexis Long, who is also a mother, desperately wants to get back to her job as a postpartum nurse, but she needs a bone marrow transplant.
1
0
1
UNC Lineberger’s Get Real & HEEL program is changing what cancer recovery looks like—one workout at a time. @SpecNews1RDU recently spotlighted how our exercise oncology team is helping patients regain strength, confidence, and community during and after treatment. @CarolineBNews.
2
1
5
RT @HemOncToday: New data shows race, insurance type and number of surgeries can impact long-term quality of life for women with ductal car….
healio.com
Race, number of surgical procedures and insurance type can significantly impact long-term mental and physical quality of life for women with ductal carcinoma in situ, according to study findings.The...
0
1
0